FDA Panel Rejects OTC Use of Montelukast (Singulair Allergy)
The Nonprescription Drugs Advisory Committee of the US Food and Drug Administration (FDA) has voted against recommending that montelukast (Singulair Allergy, Merck) be approved as an over-the-counter (OTC) drug for the treatment of allergic rhinitis …
Read more on Medscape
Make all Rx contraceptives OTC, lawyer urges FDA
Attorney and former FDA director of medical device compliance Larry R. Pilot has petitioned the agency to begin the administrative process to switch all oral contraceptives to over-the-counter status, arguing that their safety and effectiveness is well …
Read more on Medical Marketing and Media
Leave a Reply